Insider · CIK 0001346450
Atlas Venture Fund VII L P
Reports to the SEC for 4 companies · WALTHAM, MA
Transactions
15
Companies
4
Filings
4
CIK
0001346450
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2018-06-29 | LRMRLarimar Therapeutics, Inc.J Other | — |
| 2018-06-29 | LRMRLarimar Therapeutics, Inc.J Other | — |
| 2015-03-24 | LRMRLarimar Therapeutics, Inc.J Other | — |
| 2014-02-11 | Zyla Life SciencesC Conversion | — |
| 2014-02-11 | Zyla Life SciencesC Conversion | — |
| 2014-02-11 | Zyla Life SciencesX Exercise of In-Money | +$30 |
| 2014-02-11 | Zyla Life SciencesC Conversion | +$1.79M |
| 2014-02-11 | Zyla Life SciencesC Conversion | +$514K |
| 2014-02-11 | Zyla Life SciencesP Purchase | +$500K |
| 2014-02-11 | Zyla Life SciencesSeries A-1 Preferred StockC Conversion | — |
| 2014-02-11 | Zyla Life SciencesSeries B Preferred StockC Conversion | — |
| 2014-02-11 | Zyla Life SciencesWarrantsX Exercise of In-Money | — |
| 2014-02-11 | Zyla Life SciencesSubordinated Convertible DebtC Conversion | — |
| 2014-02-11 | Zyla Life SciencesSenior Convertible DebtC Conversion | — |
| 2010-03-29 | ORKAOruka Therapeutics, Inc.S Sale | −$1.06M |
Recent filings
- 4Atlas Venture Fund VII L P0001104659-18-043521SEC(opens sec.gov)
- 4ZAFGEN, INC.0001104659-15-023039SEC(opens sec.gov)
- 4Egalet Corp0001179110-14-002599SEC(opens sec.gov)
- 4ARCA biopharma, Inc.0001104659-10-017668SEC(opens sec.gov)